|
Mesa
|
MPN MCA Opening Slides 2015
|
|
|
|
Camoriano
|
MPN Conference 2015
|
|
|
|
Kralovics
|
Genetics of MPN - from Initiation to Progrssion
|
|
|
|
Stein
|
Current Guidelines in MPN Response and Therapy
|
|
|
|
Hasselbalch
|
Inflammation, Interferons and MPNs
|
|
|
|
Verstovsek
|
Evolving Management of MF
|
|
|
|
Silver
|
PV and ET in 2015
|
|
|
|
Deeg
|
Evolving role of Transplant for MPNs
|
|
|
|
Mesa
|
What Should We Expect From MPN Therapies
|
|
|
|
Leclair
|
Common MPN Labratory Questions
|
|
|
|
Michaelis
|
Gender and MPNs - What Should We Consider
|
|
|
|
Gotlib
|
Navigating the Clinical Trials Experience
|
|
|
|
Pruthi
|
New Drugs for Blood Clots - Implications for MPNs
|
|
|
|
Millstine
|
Integrative Medicine in MPNs
|
|
|
|
|
Closing Slides MPN-MCA 2015
|
|
|